Reference : Therapy for Osteoporosis. Miscellaneous and Experimental Agents

	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Rheumatology
	To cite this reference:	http://hdl.handle.net/2268/57945

Title :	Therapy for Osteoporosis. Miscellaneous and Experimental Agents
Language :	English
Author, co-author :	Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Epidémiologie et santé publique >]
	Taquet, A. N. [> > > >]
	Gosset, Christiane [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique : aspects généraux >]
Publication date :	Jun-1998
Journal title :	Endocrinology & Metabolism Clinics of North America
Volume :	27
Issue/season :	2
Pages :	453-63
Audience :	International
ISSN :	0889-8529
Abstract :	[en] None of the currently available medications for osteoporosis have demonstrated an ability to fully prevent the occurrence of new vertebral or peripheral osteoporotic fractures once the disease is established. Several new therapies, therefore, are currently being developed to optimize the risk/benefit ratio of osteoporosis treatment. This article discusses a number of treatments currently being considered, including anabolic steroids, growth hormone or insulin-like growth factors, ipriflavone, parathyroid peptides, and strontium. Several other compounds have been suggested recently for treatment of osteoporosis and other are at very early stages of their development. In addition to pharmacologic approaches to the treatment of osteoporosis, hip protectors also may reduce hip fractures.
Permalink :	http://hdl.handle.net/2268/57945
Other URL :	http://www.mdconsult.com/das/article/body/203259246-2/jorg=journal&source=&sp=10288368&sid=0/N/113277/1.html?issn=0889-8529

There is no file associated with this reference.

All documents in ORBi are protected by a user license.

 

© ULg Library Network |  Feedback |  ORBi legal notices

Dspace v1.5